Join our LinkedIn PATENTSCOPE users Community Group
Feedback
Settings

Settings

Goto Application

3,181,237 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

DS:CL

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 318,124
1.WO/2018/111327METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF JAK INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025117 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a JAK inhibitor.
2.WO/2018/182641METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IL-13 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 04.10.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025142 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-13 inhibitor. An embodiment of the disclosure relates to releasing the IL- 13 inhibitor at a location in the gastrointestinal tract of a subject that is proximate to one or more sites of disease, by administering an orally ingestible delivery device comprising such IL-13 inhibitor, said device comprise of an ingestible housing comprising a reservoir that contains the IL- 13 inhibitor, a detector coupled to the ingestible housing, a valve system in fluid communication with the reservoir, and a controller communicably coupled to the valve and the detector.
3.WO/2018/111325METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IL-6R INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61K 39/395
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
 Appl.No PCT/US2017/025102 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-6R inhibitor.
4.WO/2018/111328METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF TNF INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61M 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
31Devices for introducing or retaining media, e.g. remedies, in cavities of the body
 Appl.No PCT/US2017/025119 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TNF inhibitor.
5.WO/2018/182612METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF STEM CELLS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 04.10.2018
Int.Class A61K 35/545
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
48Reproductive organs
54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
545Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
 Appl.No PCT/US2017/024997 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a stem cell.
6.WO/2018/182623METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF CHST15 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 04.10.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025049 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a CHST15 inhibitor.
7.WO/2018/111324METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF TLR AGONISTS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025086 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TLR agonist.
8.WO/2018/111329METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IL-1 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025143 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-1 inhibitor. An embodiment of the disclosure relates to releasing the IL- 1 inhibitor at a location in the gastrointestinal tract of a subject that is proximate to one or more sites of disease, by administering an orally ingestible delivery device comprising such IL-1 inhibitor, said device comprise of an ingestible housing comprising a reservoir that contains the IL-1 inhibitor, a detector coupled to the ingestible housing, a valve system in fluid communication with the reservoir, and a controller communicably coupled to the valve and the detector.
9.WO/2018/111321METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IL-12/IL-23 INHIBITORS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025053 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-12/IL-23 inhibitor. An embodiment of the disclosure relates to releasing the IL-12/IL-13 inhibitor at a location in the gastrointestinal tract of a subject that is proximate to one or more sites of disease, by administering an orally ingestible delivery device comprising such IL-12/IL-23 inhibitor, said device comprise of an ingestible housing comprising a reservoir that contains the IL-12/IL-23 inhibitor, a detector coupled to the ingestible housing, a valve system in fluid communication with the reservoir, and a controller communicably coupled to the valve and the detector.
10.WO/2018/111326METHODS AND INGESTIBLE DEVICES FOR THE REGIO-SPECIFIC RELEASE OF IMMUNOSUPPRESSANTS AT THE SITE OF GASTROINTESTINAL TRACT DISEASE
WO - 21.06.2018
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
 Appl.No PCT/US2017/025116 Applicant PROGENITY INC. Inventor JONES, Mitchell Lawrence
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunosuppressant.
# -